Cargando…
Donor-Specific Antibodies Against Donor Human Leukocyte Antigen are Associated with Graft Inflammation but Not with Fibrosis Long-Term After Liver Transplantation: An Analysis of Protocol Biopsies
BACKGROUND: Donor-specific antibodies (DSA) against donor human leukocyte antigen after liver transplantation, which are associated with histological changes, have been widely studied with respect to their sustained impact on transplant function. However, their long-term impact after liver transplan...
Autores principales: | Gül-Klein, Safak, Hegermann, Henriette, Röhle, Robert, Schmelzle, Moritz, Tacke, Frank, Schöning, Wenzel, Öllinger, Robert, Dziodzio, Tomasz, Maier, Patrick, Plewe, Julius M, Horst, David, Sauer, Igor Maximilian, Pratschke, Johann, Lachmann, Nils, Eurich, Dennis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236257/ https://www.ncbi.nlm.nih.gov/pubmed/34188517 http://dx.doi.org/10.2147/JIR.S307778 |
Ejemplares similares
-
Treatment of Anti-HLA Donor-Specific Antibodies Results in Increased Infectious Complications and Impairs Survival after Liver Transplantation
por: Ünlü, Sinem, et al.
Publicado: (2020) -
Long-Term Outcome after Liver Transplantation for Progressive Familial Intrahepatic Cholestasis
por: Gül-Klein, Safak, et al.
Publicado: (2021) -
Liver Transplantation Is Highly Effective in Children with Irresectable Hepatoblastoma
por: Moosburner, Simon, et al.
Publicado: (2021) -
The Role of Immunosuppression for Recurrent Cholangiocellular Carcinoma after Liver Transplantation
por: Gül-Klein, Safak, et al.
Publicado: (2022) -
Minimization of Immunosuppressive Therapy Is Associated with Improved Survival of Liver Transplant Patients with Recurrent Hepatocellular Carcinoma
por: Ossami Saidy, Ramin Raul, et al.
Publicado: (2021)